Artificial heart market: A descriptive analysis of five forces model, market dynamics, and segmentation - Technavio

News provided by

Feb 08, 2023, 17:30 ET

NEW YORK, Feb. 8, 2023 /PRNewswire/ -- According to Technavio, the global artificial heart market size is estimated to grow by USD 1.86 billion from 2021 to 2026. The market is estimated to grow at a CAGR of 11.8% during the forecast period. Moreover, the growth momentum will accelerate. North America will account for 49% of the market's growth during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. For more insights on market size, request a sample report

Technavio has announced its latest market research report titled Global Artificial Heart Market 2022-2026

Artificial heart market - Five forces
The global artificial heart market is fragmented, and the five forces analysis covers–

Bargaining power of buyers
The threat of new entrants
Threat of rivalry
Bargaining power of suppliers
Threat of substitutes
For an interpretation of Porter's five forces model – Buy the report!

Artificial heart market – Customer landscape

The report includes the market's adoption lifecycle, from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Artificial heart market - Segmentation assessment

Segment overview
Technavio has segmented the market based on product (VAD and TAH).

The VAD segment will account for a significant share of the market's growth during the forecast period. Left ventricular assist device (LVAD) and right ventricular assist device (RVAD) are the two main types of VAD. LVAD, which is also known as ventricular assist system (VAS), is a surgically implanted mechanical pump that removes blood from the left ventricle and pumps it out through the aorta to the rest of the body. The prevalence of advanced HF, the global shortage of suitable donor hearts available for transplantation, and favorable reimbursement policies in countries such as the US are some of the key factors behind the growth of this segment.

Geography overview
Based on geography, the global artificial heart market is segmented into North America, Europe, Asia, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global artificial heart market.

North America will account for 49% of the market's growth during the forecast period. The US is a key contributor to the artificial hearts market in North America. Moreover, market growth in this region will be faster than the growth of the market in Rest of World (ROW). Factors such as the high prevalence of HF and associated risk factors, favorable reimbursement policies, improved healthcare infrastructure, access to advanced healthcare, and the strong presence of established vendors will drive the artificial heart market growth in North America during the forecast period.

Download a sample report

Artificial heart market – Market dynamics
Key factor driving market growth

The increasing prevalence of HF and associated risk factors are driving the growth of the market.
In Europe, HF affects 20,000 out of a million people. In the US, 800,000 to a million patients are diagnosed with HF annually.
The prevalence of HF increases with age. In 2018, there were approximately 650 million people aged 65 years and above globally, and the number is estimated to increase to approximately 910 million by 2030.
In addition, the associated risk factors of HF, such as blood pressure, obesity, smoking, and alcohol consumption, are also rising.
Such factors will fuel the market growth during the forecast period.

Leading trends influencing the market

Clinical trials for the development of TAHs are a key trend in the market.
Vendors are increasing their R&D efforts for innovative TAHs. For instance, BiVACOR Inc. is developing a small and compact TAH called BiVACOR, which can replace the total function of the native heart.
CARMAT is developing the first auto-regulating bioprosthetic TAH called CARMAT. The company aims to offer a long-term therapeutic solution to patients who are not eligible for transplantation.
May such products or technologies are expected to enter the market during the forecast period.
These factors will support the market's growth during the forecast period.

Major challenges hindering market growth

The high cost of artificial hearts is challenging the market growth.
Vendors charge high prices due to factors such as a complex and expensive regulatory approval process and patent protection.
The cost of a VAD is about USD 100,000, depending on the type and the country.
The price of a TAH transplant is in the range of USD 125,000 to USD 150,000, and the maintenance cost is about USD 18,000 each year.
In addition, procedural costs for artificial hearts can increase significantly, depending on the type of device used, the extent of surgery, surgeon's skill, complications involved, hospital costs, special tests, insurance coverage, and medications required.
Such factors are expected to hinder the growth of the market during the forecast period

Drivers, trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

What are the key data covered in this artificial heart market report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the artificial heart market between 2022 and 2026
Precise estimation of the size of the artificial heart market and its contribution to the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the artificial heart market across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market's competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of Artificial Heart Market vendors

Gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Related Reports:

The artificial eye market size is expected to increase by USD 34,140.17 thousand from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.16%. This report extensively covers segmentation by product (integrated prosthetic eye, non-integrated prosthetic eye, and retinal prosthetics) and geography (North America, Europe, Asia, and Rest of World (ROW)).

The artificial retina market size is expected to increase by USD 9.43 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.54%. This report extensively covers segmentation by disease type (macular degeneration and diabetic retinopathy) and geography (North America, Europe, Asia, and Rest of World (ROW)).

Artificial Heart Market Scope
Report Coverage	Details
Page number	132
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 11.8%
Market growth 2022-2026	USD 1.86 billion
Market structure	Fragmented
YoY growth 2021-2022 (%)	11.24
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 49%
Key countries	US, Germany, France, Japan, and China
Competitive landscape	Leading vendors, market positioning of vendors, competitive strategies, and industry risks
Key companies profiled	Abbott Laboratories, Abiomed Inc., Berlin Heart GmbH, BiVACOR Inc., Boston Scientific Corp., Calon Cardio-Technology Ltd, CARMAT SA, Corcym Srl, CorWave SA, Edwards Lifesciences Corp., Evaheart Inc., Jarvik Heart Inc., Medtronic Plc, MyLVAD Foundation LTD., Quest Diagnostics Inc., SynCardia Systems LLC, Artivion Inc., JenaValve Technology Inc., LivaNova Plc, and Terumo Corp.
Market dynamics	Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio's health care market reports

Table of contents

1 Executive Summary

1.1 Market overview

Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
Exhibit 06: Executive Summary – Chart on Incremental Growth
Exhibit 07: Executive Summary – Data Table on Incremental Growth
Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem

Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition

Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis

Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary

Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

4.2 Bargaining power of buyers

Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026

4.3 Bargaining power of suppliers

Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants

Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes

Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry

Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition

Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments

Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)

5.2 Comparison by Product

Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product

5.3 VAD - Market size and forecast 2021-2026

Exhibit 28: Chart on VAD - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on VAD - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on VAD - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on VAD - Year-over-year growth 2021-2026 (%)

5.4 TAH - Market size and forecast 2021-2026

Exhibit 32: Chart on TAH - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on TAH - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on TAH - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on TAH - Year-over-year growth 2021-2026 (%)

5.5 Market opportunity by Product

Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

6.1 Customer landscape overview

Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation

Exhibit 38: Chart on Market share by geography 2021-2026 (%)
Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison

Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026

Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026

Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026

Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026

Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026

Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 Germany - Market size and forecast 2021-2026

Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.9 France - Market size and forecast 2021-2026

Exhibit 66: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on France - Year-over-year growth 2021-2026 (%)

7.10 Japan - Market size and forecast 2021-2026

Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)

7.11 China - Market size and forecast 2021-2026

Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)

7.12 Market opportunity by geography

Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges

Exhibit 79: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape

Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption

Exhibit 81: Overview on factors of disruption

9.4 Industry risks

Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered

Exhibit 83: Vendors covered

10.2 Market positioning of vendors

Exhibit 84: Matrix on vendor position and classification

10.3 Abbott Laboratories

Exhibit 85: Abbott Laboratories - Overview
Exhibit 86: Abbott Laboratories - Business segments
Exhibit 87: Abbott Laboratories - Key news
Exhibit 88: Abbott Laboratories - Key offerings
Exhibit 89: Abbott Laboratories - Segment focus

10.4 Abiomed Inc.

Exhibit 90: Abiomed Inc. - Overview
Exhibit 91: Abiomed Inc. - Business segments
Exhibit 92: Abiomed Inc. - Key news
Exhibit 93: Abiomed Inc. - Key offerings
Exhibit 94: Abiomed Inc. - Segment focus

10.5 Berlin Heart GmbH

Exhibit 95: Berlin Heart GmbH - Overview
Exhibit 96: Berlin Heart GmbH - Product / Service
Exhibit 97: Berlin Heart GmbH - Key offerings

10.6 BiVACOR Inc.

Exhibit 98: BiVACOR Inc. - Overview
Exhibit 99: BiVACOR Inc. - Product / Service
Exhibit 100: BiVACOR Inc. - Key offerings

10.7 Calon Cardio-Technology Ltd

Exhibit 101: Calon Cardio-Technology Ltd - Overview
Exhibit 102: Calon Cardio-Technology Ltd - Product / Service
Exhibit 103: Calon Cardio-Technology Ltd - Key offerings

10.8 CARMAT SA

Exhibit 104: CARMAT SA - Overview
Exhibit 105: CARMAT SA - Business segments
Exhibit 106: CARMAT SA - Key offerings
Exhibit 107: CARMAT SA - Segment focus

10.9 Jarvik Heart Inc.

Exhibit 108: Jarvik Heart Inc. - Overview
Exhibit 109: Jarvik Heart Inc. - Product / Service
Exhibit 110: Jarvik Heart Inc. - Key offerings

10.10 Medtronic Plc

Exhibit 111: Medtronic Plc - Overview
Exhibit 112: Medtronic Plc - Business segments
Exhibit 113: Medtronic Plc - Key news
Exhibit 114: Medtronic Plc - Key offerings
Exhibit 115: Medtronic Plc - Segment focus

10.11 Quest Diagnostics Inc.

Exhibit 116: Quest Diagnostics Inc. - Overview
Exhibit 117: Quest Diagnostics Inc. - Business segments
Exhibit 118: Quest Diagnostics Inc. - Key offerings
Exhibit 119: Quest Diagnostics Inc. - Segment focus

10.12 SynCardia Systems LLC

Exhibit 120: SynCardia Systems LLC - Overview
Exhibit 121: SynCardia Systems LLC - Product / Service
Exhibit 122: SynCardia Systems LLC - Key offerings

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist

Exhibit 123: Inclusions checklist
Exhibit 124: Exclusions checklist

11.3 Currency conversion rates for US$

Exhibit 125: Currency conversion rates for US$

11.4 Research methodology

Exhibit 126: Research methodology
Exhibit 127: Validation techniques employed for market sizing
Exhibit 128: Information sources

11.5 List of abbreviations

Exhibit 129: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio